Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system.
about
Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersTargeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro studyFunctional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.HIV-1 proteins, Tat and gp120, target the developing dopamine systemCocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTRMethamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.Yin and Yang of PDGF-mediated signaling pathway in the context of HIV infection and drug abuse.TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway.Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways.Animal models for depression associated with HIV-1 infection.HIV-associated synaptic degeneration.Opposing Effects of NGF and proNGF on HIV Induced Macrophage Activation.
P2860
Q26865707-3459B008-91D6-4AD9-BB32-8361A8775C76Q27025573-677F3CD4-9326-4275-B726-F281E862031BQ28487323-EA6DF87A-D50B-4394-A7E3-164B59613E88Q30416710-AE4968BD-FBE9-4F79-99BC-919225A6D343Q35023230-F89BF6DB-D4D0-4A67-8224-05F0CB9FCF40Q35088011-1D2273B8-F157-4E86-82AE-F896645A2A24Q35743630-223C75E7-1F53-4579-BC85-3200E5CBF136Q35894061-36216512-D506-40C6-A339-48B3119BA738Q36313032-1D82781B-4227-4B91-95AC-E99B1355D8FBQ37397206-8DD10C64-4BD8-4608-9588-7BD3CD7179B8Q37441375-39446CFA-7778-4647-8BD4-87B095CF8477Q38122650-63D7C1A8-A9E7-457E-B657-553200B006E4Q38171363-50584F59-B890-44A0-B3B3-E232611FDD54Q40066321-0CC22699-992C-4813-B552-027B83EB360FQ40974724-AB061305-9F20-4477-AD6B-015DD832DC88
P2860
Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brain-derived neurotrophic fac ...... the rat nigrostriatal system.
@en
Brain-derived neurotrophic fac ...... the rat nigrostriatal system.
@nl
type
label
Brain-derived neurotrophic fac ...... the rat nigrostriatal system.
@en
Brain-derived neurotrophic fac ...... the rat nigrostriatal system.
@nl
prefLabel
Brain-derived neurotrophic fac ...... the rat nigrostriatal system.
@en
Brain-derived neurotrophic fac ...... the rat nigrostriatal system.
@nl
P2093
P2860
P356
P1476
Brain-derived neurotrophic fac ...... n the rat nigrostriatal system
@en
P2093
Edwin M Meyer
Italo Mocchetti
Rachel L Nosheny
P2860
P304
P356
10.1196/ANNALS.1403.010
P407
P577
2007-12-01T00:00:00Z